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Abstract
Background: Over its life cycle, the Plasmodium falciparum parasite is exposed to different environmental
conditions, particularly to variations in O2 pressure. For example, the parasite circulates in human venous blood at
5% O2 pressure and in arterial blood, particularly in the lungs, at 13% O2 pressure. Moreover, the parasite is
exposed to 21% O2 levels in the salivary glands of mosquitoes.
Methods: To study the metabolic adaptation of P. falciparum to different oxygen pressures during the
intraerythrocytic cycle, a combined approach using transcriptomic and proteomic techniques was undertaken.
Results: Even though hyperoxia lengthens the parasitic cycle, significant transcriptional changes were detected in
hyperoxic conditions in the late-ring stage. Using PS 6.0™ software (Ariadne Genomics) for microarray analysis, this
study demonstrate up-expression of genes involved in antioxidant systems and down-expression of genes involved
in the digestive vacuole metabolism and the glycolysis in favour of mitochondrial respiration. Proteomic analysis
revealed increased levels of heat shock proteins, and decreased levels of glycolytic enzymes. Some of this
regulation reflected post-transcriptional modifications during the hyperoxia response.
Conclusions: These results seem to indicate that hyperoxia activates antioxidant defence systems in parasites to
preserve the integrity of its cellular structures. Moreover, environmental constraints seem to induce an energetic
metabolism adaptation of P. falciparum. This study provides a better understanding of the adaptive capabilities of
P. falciparum to environmental changes and may lead to the development of novel therapeutic targets.
Background
Plasmodium falciparum is a protozoan parasite respon-
sible for the most severe form of human malaria. This
infection causes between 708,000 and 1,003,000 human
deaths each year, most of them occurring in African
children under the age of five years [1]. Several anti-
malarial agents are used for malaria treatment and pro-
phylaxis in endemic regions. However, the expansion of
drug-resistance remains a serious problem. To develop
new anti-malarial drugs, a better understanding of
P. falciparum biology is required [2]. Some unique prop-
erties of the P. falciparum mitochondrion indicate that
its respiratory metabolism could be exploited to gener-
ate chemotherapeutic targets [3]. Indeed, atovaquone,
a mitochondrial cytochrome bc1 complex inhibitor, is
currently used in combination with proguanil (Malar-
one™, GlaxoSmithKline) for malaria treatment and
prophylaxis [4,5].
In vitro, P. falciparum growth is maximal in limited
oxygen content (0.5%-5.0% O2), so the parasite is con-
sidered as a microaerophilic organism. In vivo, the para-
site life cycle involves two hosts: the mosquito and the
human, during which the parasite undergoes different
cellular morphological changes and experiences oxygen
pressure variations. The passage from one host to
another implies metabolic adaptation and changes in the
ultrastructural and physiological organization of mito-
chondria [6-8]. In humans, the parasite is exposed to
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in lung capillaries [9]. In mosquitoes, the parasite is
exposed to 21% O2 levels in salivary glands. To adapt to
these environmental constraints, the parasite has devel-
oped metabolic adaptations essential for it survival. Dur-
ing the intraerythrocytic cycle, two metabolic pathways
are the major sources of ROS (superoxide anions,
hydrogen peroxide and hydroxyl radicals) on P. falciparum
- the mitochondrial respiratory chain and haemoglobin
digestion [10]. In the presence of oxygen, P. falciparum
can produce ATP by aerobic respiration and through gly-
colysis. Accordingly, microaerophilic metabolism may be
a metabolic adaptation to prevent oxidative stress genera-
tion [10,11]. The parasite also consumes haemoglobin in
its digestive vacuole for protein biosynthesis. This meta-
bolic pathway is a source of superoxide anions and ferri-
protoporphyrin IX (FIX) accumulation [12], and thus
ROS produced in the mitochondria could interact
with these products of haemoglobin digestion and
increase oxidative damage to the parasite cells. Therefore,
P. falciparum has developed a preventive defence system
to reduce cellular damage.
To identify metabolic pathways involved in the hyper-
oxia response, the effect of oxygen on P. falciparum was
studied using high-throughput transcriptomic and pro-
teomic analyses in the late-ring stage. These approaches
were designed to minimize non-specific responses [13],
and they revealed that a stress response occurs following
parasite exposure to hyperoxia and that P. falciparum
modifies the metabolism of two organelles (the mito-
chondrion and the digestive vacuole) as a metabolic
adaptation to this environmental challenge.
Methods
Plasmodium falciparum in vitro culture
The 3D7 P. falciparum strain (the reference strain used
for the genome sequencing project) was obtained from
the Malaria Research and Reference Reagent source cen-
tre (MR4, managed by the American type culture collec-
tion). Parasitized human red blood cells (RBC type A+)
were maintained in culture in RPMI 1640 medium (Invi-
trogen, Paisley, United Kingdom) supplemented with
10% human serum and buffered with 25 mM HEPES
(Sigma-Aldrich, St Louis, MI, USA) and 25 mM NaCO3
(Sigma) and in an atmosphere of 5% O2,5 %C O 2,a n d
90% N2 [14]. The haematocrit was maintained at 6%
and the parasitaemia at 3-5%. Culture medium was
changed every day. Strain clonality was verified every
month using PCR genotyping of polymorphic genetic
markers (msp1, msp2 and microsatellite loci) [15,16].
Plasmodium falciparum culture synchronization
To obtain tightly synchronized parasite cultures, several
synchronization steps were successively employed. First,
parasitized erythrocytes were treated with D-sorbitol
(ICN Biomedicals, Inc., CA, United States of America)
as previously described [17]. This step enriched cultures
in the ring parasite stage. Secondly, in the next parasitic
cycle, schizonts were selected using CS columns on
a VarioMACS unit (Miltenyi Biotec, Germany) according
to standard procedures [18]. Five hours later, the culture
was treated with 5% D-sorbitol to eliminate parasites in
mature stages (schizonts). These successive parasite syn-
chronization steps allowed us to obtain parasites tightly
synchronized in the ring stage (the window from 0 to 5 h
after parasite invasion of the erythrocyte). The synchro-
nized parasites were maintained in standard culture con-
ditions before treatment.
Hyperoxia exposure of P. falciparum cultures
Tightly synchronized cultures (ring stage aged between
4-9 hours) were split and subjected to two different con-
ditions, either a normoxic atmosphere (5% O2,5 %C O 2,
90% N2 gas mixture) or a hyperoxic atmosphere (21%
O2,5 %C O 2, 74% N2 gas mixture) at 37°C in two series
II incubators (Model 3131, Forma Scientific, Inc.). Cul-
ture conditions were maintained over eight hours for
transcript analysis (parasites aged between 12-17 hours)
and for 12 hours for protein analysis (parasites aged
between 16-21 hours). For each culture condition, four
biological replicates were performed. Viability, parasitae-
mia and erythrocytic cycle stage proportions were moni-
tored daily by examining blood smears stained with
RAL
® 555 (RAL, Martillac, France). Blood smears were
taken at 0, 24, 32, 36, 48, and 78 hours.
RNA extraction
After incubation under normoxic or hyperoxic atmo-
spheric conditions, total RNA from parasitized erythro-
cytes was extracted with TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. RNA
extracts were treated with 1 U of RNase-free DNase I
(Applied Biosystems, CA, United States of America) and
quantified using a NanoDrop ND-1000 (Nanodrop
Technologies, Wilmington, United States of America).
The integrity of the RNA was controlled with an RNA
nano chip (2100 Bioanalyzer, Agilent Biotechnologies,
Wilmington, DE). Samples were immediately used or
stored at - 80°C.
Microarray experiments and analysis
A 2X11 k custom P. falciparum whole genome microar-
ray was designed and manufactured using SurePrint
Inkjet technology
® (Agilent Technologies). In brief, the
microarray was composed of 10,128 sixty-mer oligonu-
cleotides representing 5,364 coding sequences located in
the chromosomal, apicoplastic and mitochondrial gen-
omes. Additional probes were added to control for
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following the manufacturer’sp r o t o c o l( T w o - C o l o r
Microarray-Based Gene Expression Analysis, Agilent
Technologies). Briefly, starting with 300 ng of total
RNA, fluorescent cRNA (antisense) was generated using
the Low RNA Input Fluorescent Amplification Kit (Agi-
lent Technologies) and either cyanine 3-labeled CTP
(Cy-3) or cyanine 5-labeled CTP (Cy-5) fluorescent dyes
(PerkinElmer Life Sciences, Boston, MA). Dye swap
hybridization was performed for 17 h at 60°C using the
In situ Hybridization Kit Plus (Agilent Technologies).
All processing steps were performed in an ozone-
controlled environment ([O3]<2p p b )t oa v o i do z o n e -
induced degradation of cyanine dyes on microarray
slides. Slides were scanned at 5 μm resolution with
a G2505B DNA microarray scanner (Agilent Technolo-
gies). Image analysis and intra-array signal correction
was performed using the Agilent Feature Extractor Soft-
ware A.9.1.3. Data processing, analysis and visualization
were performed using the Resolver software 7.1 (Rosetta
Inpharmatics). An error model-based transformation
pipeline was used to map replicate reporters to genes,
perform inter-array normalization and calculate fold
changes (FC) as described elsewhere [19]. Using these
FC values, a gene set enrichment analysis (GSEA) was
performed using the Mann-Whitney-U-test enrichment
algorithm in the PathwayStudio software 6.0 (PS 6.0™,
Ariadne Genomics). The GSEA procedure determines
whether the behaviour of an ap r i o r iset of genes shows
significant concordance across two different biological
states. This GSEA analysis focuses on groups of genes
that share common biological function in revealing dif-
ferential levels of each transcript. A gene network was
generated based on information extracted from the lit-
erature using Medscan™ and the P. falciparum-specific
database PS 6.0™ and using the “physical or regulatory
connections” parameter between genes. Fold change
values of microarray data were imported into PS 6.0™
and used to interpret the pathway with gene regulation
networks.
Real-time quantitative RT-PCR
cDNA was synthesized from total RNA (DNA-free) with
random hexamers using the High-Capacity cDNA
Archive Kit (Applied Biosystems). Primers with a melt-
ing temperature between 55 to 60°C were designed to
yield a 94- to 146-bp product preferentially containing
an exon/intron boundary. Specific primer sequences
used for the qRT-PCR are summarized in Additional
data (Additional file 1). Real-time PCR was performed
using the 7900 HT Fast Real-Time PCR System
(Applied Biosystems) in a 25-μL reaction volume with
the Power SYBR Green
® PCR Master Mix Kit (Applied
Biosystems). Each sample was assayed in triplicate and
analysed with the ABI PRISM Sequence Detection Sys-
tem software Version SDS 2.2.1 (Applied Biosystems).
Amplification of the 18S rRNA sequence served as the
internal control for normalization. At the end of each
reaction, cycle threshold (Ct) was manually set to the
level that reflected the best kinetic PCR parameters, and
melting curves were acquired and analysed. Relative
quantification analysis was performed using the 2-ΔΔCt
method where ΔΔCt = (Cttarget -C t 18S rRNA)H- (Cttarget -
Ct18S rRNA)N., and the data reflect changes in target gene
expression between two experimental conditions (N:
normoxic and H: hyperoxic groups) [20].
Protein sample preparation and CyDye labelling
After incubation under normoxic or hyperoxic atmo-
spheric conditions, parasitized erythrocytes were washed
three times in PBS medium (Invitrogen) and lysed in
cold H2O-saponin (0.1%, Sigma) for 10 min. The lysate
was then centrifuged at 1500 g for 5 min. The superna-
tant was discarded and the pellet containing free para-
sites was recovered by washing in PBS medium followed
by a centrifugation step (1500 g for 5 min). The free
parasites were washed until the supernatant became col-
ourless. The pellet was then suspended in 4% (w/v)
CHAPS (Sigma) and disrupted by ultrasonication
(Vibracell 72412, Bioblock Scientific, Illkirch, France)
five times for 60 seconds on ice at maximum amplitude.
The lysate was then centrifuged at 16000 g for 15 min.
The supernatant was further precipitated with acetone
100% (Sigma). The protein concentration for each sam-
ple was estimated using the BioRad Lowry-based DC
assay (Biorad, Hercules, CA, USA) according to the
manufacturer’s instructions. Total proteins were sus-
pended in standard cell lysis buffer (7 M urea, 2 M
thiourea, 4% CHAPS, 30 mM Tris base, pH 8.5 (Sigma))
to obtain a protein concentration adjusted to 2.5 μg/μL.
Protein samples were minimally labelled with CyDye
according to the manufacturer’s protocols (GE Health-
care, Piscataway, NJ) [21]. The mixture of labelled pro-
teins was then separated by two-dimensional (2D)
electrophoresis.
Two-dimensional electrophoresis, image analysis and in-
gel digestion
Isoelectric focusing (IEF) was performed on 18-cm 3-10
linear IPG strips (GE Healthcare). Destreak buffer con-
taining 1% (v/v) IPG buffer 3-10 was used for overnight
rehydration of IPG strips. The samples were applied at
the acidic end of the IPG strip using a cup-loading tech-
nique. IEF was carried out on a Ettan IPGphor II (GE
Healthcare) electrophoresis unit at 20°C for a total of 45
kVh (ramp to 300 V in 3 hrs, ramp to 1000 V in 6 hrs,
ramp to 8000 V in 3 hrs, hold at 8000 V for 4 hours).
IPG strips were equilibrated in equilibration buffer
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SDS and 30% glycerol supplemented with 1% (w/v)
DTT for 15 min at room temperature, followed by pro-
tein alkylation (carbamidomethylation) in the same equi-
libration buffer containing 2.5% (w/v) iodoacetamide
instead of DTT for 15 min at room temperature. IPG
strips were then placed on the top of 10% uniform poly-
acrylamide gels. Strips were overlaid with 0.5% agarose
in 1× running buffer containing bromophenol blue and
the proteins were further separated by SDS-PAGE (10
W per gel) at 20°C in an Ettan DALT Six electrophor-
esis system (GE Healthcare). After electrophoresis, the
gels with Cydye-labelled proteins were directly imaged
using a Typhoon™ Trio Image scanner (GE Healthcare
UK). The intensity was adjusted to ensure that the maxi-
mum volume of each image was within 60,000 - 80,000 U.
Analysis of 2-D DIGE was performed with DeCyder 6.5
software (GE Healthcare) using the differential in-gel
analysis (DIA) and the biological variation analysis (BVA)
modules. Protein spots that were expressed differentially
between two experimental conditions (|ratio|≥1.5, p ≤
0.05 t-Test) were marked with master gel numbers.
Based on DeCyder v6.5 analysis, spots of interest from
gels stained with Imperial Blue Stain (Pierce) were
excised and digested using a Shimadzu Xcise automated
gel processing platform (Shimadzu Biotech, Kyoto, Japan)
as described previously [22] and stored at -20°C.
Mass spectrometry analysis
The samples were analysed by nanoscale capillary liquid
chromatography-tandem mass spectrometry (nano LC-
MS/MS). Purification and analysis were performed on
a C18 capillary column using a CapLC system (Waters,
Milford, MA) coupled to a hybrid quadrupole orthogo-
nal acceleration time-of-flight tandem mass spectro-
meter (Q-TOF Ultima, Waters, MA). Chromatographic
separation was conducted on a reversed-phased capillary
column (Atlantis™ dC18, 3 μm, 75 μm × 150 mm Nano
Ease™, Waters, MA) with a 180-200 nl min
-1 flow. The
gradient profile consisted of a linear gradient from 95%
A( H 2O, 0.1% HCOOH) to 60% B (80% ACN, 0.1%
HCOOH) in 60 min followed by a linear gradient to
95% B in 10 min. Mass data acquisitions were piloted by
MassLynx 4.0 software using automatic switching
b e t w e e nM Sa n dM S / M Sm o d e s .T h ei n t e r n a lp a r a -
meters of Q-TOF were set as follows. The electro-spray
capillary voltage was set to 3.2 kV, the cone voltage was
set to 30 V, and the source temperature was set to 80°C.
The MS survey scan was m/z 400-1300 with a scan time
of 1 s and an interscan time of 0.1 s. When the intensity
of a peak rose above a threshold of 15 counts, tandem
mass spectra were acquired. Normalized collision ener-
gies for peptide fragmentation were set using the
charge-state recognition files for +2 and +3 peptide
ions. The scan range for MS/MS acquisition was from
m/z 50 to 1500 with a scan time of 1 s and an interscan
time of 0.1 s. Fragmentation was performed using argon
as the collision gas and with the collision energy profile
o p t i m i z e df o rv a r i o u sm a s sr a n g e sa n dc h a r g e so fp r e -
cursor ions. Mass data collected during a nano LC-MS/
MS analysis were processed using ProteinLynx Global
Server 2.2 software (Waters) with the following para-
meters: no background subtraction, smooth 3/2 Savitzky
Golay and no deisotoping to generate peak lists in the
micromass pkl format. Pkl files were then fed into the
local search engine Mascot Daemon v2.2.2 (Matrix
Science, London, UK). The data were searched against
the Homo sapiens (218356 sequences) and P. falciparum
(13110 sequences) National Center for Biotechnology
Information non-redundant (NCBInr) protein database
(March, 2010). Search parameters allowed for one
missed tryptic cleavage site, the carbamidomethylation
of cysteine, and the possible oxidation of methionine;
precursor and product ion mass error tolerance was <
0.2 Da. All identified proteins had a Mascot score
greater than 29 and 38 respectively for P. falciparum
and Homo sapiens, corresponding to statistically signifi-
cant (p ≤ 0.05 t-Test) identification. Identifications were
considered valid when they contained at least two pep-
tide sequences per protein. If a single peptide sequence
was identified per one protein, the mascot score and
sequence coverage were taken into account (Additional
file 2).
Results
Effect of hyperoxia on P. falciparum and experimental
design
To determine the effects of hyperoxia on asexual blood
stage P. falciparum parasites, tightly synchronized cul-
tures of the 3D7 strain were exposed to normoxic (5%
O2)a n dh y p e r o x i c( 2 1 %O 2) conditions for two life
cycles. The proportion of parasitaemia and erythrocytic
cycle stages were monitored by blood smears in tripli-
cate at different times: 0, 24, 32, 36, 48, and 78 hours
(Figure 1). In normoxic condition, the 3D7 P. falciparum
strain had a life cycle of 45 hours with entry into schi-
zogony at approximately 32 hours. Parasite exposure to
21% O2 increased the length of parasitic cycle and
decreased the parasitaemia, but it did not alter the para-
sites morphology (Figure 1). At 48 hours, the second
parasitic cycle began for parasites exposed to 5% O2
(nearly all of them were at ring stage (100%)), while the
majority of parasites exposed to 21% O2 remained in
the schizont stage (90% schizonts and 10% ring). Thus,
hyperoxia induces a delay of P. falciparum cell cycle of
four hours as previously described [23]. After reinvasion
during the following cycle (third cycle), hyperoxia expo-
sure did not change parasitaemia and parasites had a
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data). These results seem to indicate a biological adap-
tation of the parasite to hyperoxia. To study the effects
of hyperoxia on P. falciparum,c o m p l e m e n t a r yh i g h -
throughput transcriptomic and proteomic approaches
were used. Transcriptome and proteome profiles from
parasitized RBCs exposed to normoxic (5% O2)o r
hyperoxic (21% O2) atmospheric conditions were com-
pared. The results were controlled by the experimental
design on two levels: (i) the percentage of atmospheric
oxygen and (ii) the timing of the parasitic stage. First,
hyperoxic exposure was chosen at 21% O2 in light of
the above data [23]. Second, transcriptome and pro-
teome experiments were performed at the late-ring
stage, after RBC reinvasion with a synchronization win-
d o wo ff o u rh o u r s .T h i ss t a g ea l l o w e du st oa v o i dt h e
effects of cycle delay.
Plasmodium falciparum response to hyperoxia treatment:
microarray analysis
To investigate the response of P. falciparum to hyper-
oxia, the 3D7 strain was cultured in vitro under nor-
moxic (5% O2) and hyperoxic (21% O2) atmospheric
conditions. Three biological replicates in each group
were performed and comparisons were made with
a dye-swap experimental scheme. The raw microarray
data are available in the Gene Expression Omnibus
database [platform GPL9482 and samples from
GSM466802 to GSM466807, 2010 [24]]. Among 5,364
coding sequences represented on the microarray, 219
genes were significantly altered following hyperoxia
exposure (p ≤ 0.01, Student’s t-Test,| F C | ≤ 1.5, Addi-
tional file 3), among which 114 were up-expressed and
105 were down-expressed. Based on the selected 219
genes, a GSEA (FDR ≤ 0.05) was performed [25], and
this allowed us to define 9 functional groups that were
significantly altered (following hyperoxia treatment)
(Additional file 4 and Table 1). Among these functions,
“DNA repair,”“ Vacuolar acidification” and “Response to
oxidative stress” were previously reported to be involved
in the hyperoxia response [10,26-30].
GSEA data were first integrated to create a gene net-
work based on information extracted from the literature
using Medscan™ and PS 6.0™ (Ariadne Genomics). Next,
the expression levels of genes included in the gene net-
work were assigned using PS 6.0™ and microarray expres-
sion data. This programme gives a dynamic view of
metabolism during the hyperoxia response (Figures 2A
and 2B). Thus, PS 6.0 analysis clustered 28 modulated-
expression genes in five metabolic groups labelled
“Energetic metabolism,”“ Protein folding,”“ Signal Trans-
duction,”“ DNA repair” and “Translation” (Figure 2A).
This transcriptomic analysis allowed us to identify
up-regulated genes involved in DNA repair and protein
folding and down-regulated genes linked to PKA-dependent
signal transduction and glycolysis (Figure 2A). Addition-
ally, PS 6.0 software revealed an alteration of an ATP-
dependent sub-network: specifically, up-regulation of
the mitochondrial ATP synthase complex and down-
regulation of the V-type ATPase complex (Figure 2B).
To confirm the GSEA data, eight genes presenting sig-
nificant variations in expression were quantified using
real-time qRT-PCR (Additional file 1). These genes,
which were involved in glycolysis [PlasmoDB: PF14_
0598, PF10_0245], antioxidant metabolism [PlasmoDB:
PF14_0187, PF11_0087], signal transduction [PlasmoDB:
PFL1110c, PFI1685w] and ATP synthase activity [Plas-
moDB: PF10_0059, MAL7P1.13] were chosen according
Figure 1 Lengthening of P. falciparum cell cycle following
hyperoxia exposure. Phenotypic changes in P. falciparum asexual
blood stages were observed during two cycles under normoxic
(A) and hyperoxic (B) conditions. The parasitaemia and parasitic
stages were evaluated by blood smears at different times: 0, 24, 32,
36, 48, and 78 hours. The different intraerythrocytic stages and their
corresponding percentages are indicated as follows: ring (R),
trophozoite (T) and schizont (S).
Table 1 Biological functions perturbed following
hyperoxia exposure on P. falciparum
Functional group
a Number of entities
b p-value
c
GPI anchor biosynthesis 29 0.0006
DNA repair 15 0.0072
Vacuolar acidification 11 0.0255
Actin filament organization 12 0.0296
Nucleosome assembly 12 0.0490
Regulation of cell shape 6 0.0519
Leading strand elongation 10 0.0533
Lysosomal H+ import 26 0.0589
Response to oxidative stress 17 0.0799
aGene Set Enrichment Analysis (GSEA) using the Mann-Whitney-U-test
enrichment algorithm in PathwayStudio software indicated functional groups
significantly altered (p < 0.08). For each functional group, the
bnumber of
genes included and corresponding
cp-values are listed.
Torrentino-Madamet et al. Malaria Journal 2011, 10:4
http://www.malariajournal.com/content/10/1/4
Page 5 of 15to their essential functions in response to hyperoxia.
qRT-PCR was performed on total RNA extracted from
the same three samples used for microarray analysis.
Correlation coefficients for each specific-gene standard
curve were always > 0.99 (unpublished data). Gene
amplification was normalized by 18S rRNA [PlasmoDB:
MAL7_18Sa] levels as previously described [31]. The
two analyses (qRT-PCR and microarray) yielded consis-
tent results for all the genes evaluated (Figure 3).
Plasmodium falciparum response to hyperoxia treatment:
proteomic analysis
To identify P. falciparum proteins involved in the hyper-
oxia response, 2D-DIGE experiments coupled to
MS were performed. Four independent cultures of
P. falciparum cultivated under normoxic and hyperoxic
conditions were included in this analysis. After protein
separation on 2-DE, each gel was individually imaged
and all gel images were analysed using the DeCyder 6.5
software. Among 1840 protein spots matched, 33 spots
were significantly modulated (|FC|≥1.5, p ≤ 0.05 t-Test)
following hyperoxia treatment (14 and 19 spots were
up- and down-modulated, respectively; Figure 4). All
spots were successfully identified by MS and corre-
sponded to 14 Homo sapiens and 19 P. falciparum pro-
teins (Table 2 and Additional file 5). However, some
proteins were detected in more than one spot, indicating
different isoforms. Indeed, only six proteins were identi-
fied for Homo sapiens and 13 for P. falciparum (Table 2).
These results indicated that hyperoxia induced protein
Figure 2 Gene networks involved in the metabolic adaptation to hyperoxia in tightly synchronized P. falciparum cultures.U s i n gP S
6.0™ software and microarray expression data, gene networks were built and genes modulated in response to hyperoxia are represented. (A)
Representation of metabolic interrelations related to adaptative hyperoxia exposure. Energetic metabolism: aspartate carbamoyltransferase
(P13_0240), carbamoyl-phosphate synthetase (PF13_0044), glutamine-fructose-6-phosphate transaminase (PF10_0245), glucose-6-phosphate
dehydrogenase (PF14_0511), acetyl-CoA synthetase (PFF1350c), gapdh (PF14_0598) - Signal transduction: regulatory sub-unit of cAMP-dependent
protein kinase (PFL1110c), catalytic sub-unit of cAMP-dependent protein kinase (PFI1685w), ser thr protein kinase (PF13_0085) - Translation: citrate
synthase (PF10_0218), translation elongation factor 1 alpha 1 (PF13_0305), proteasome 26S subunit (MAL13P1.343), dihydrolipoamide dehydrogenase
(PFL1550w), translation elongation factor 2 (PF14_0486), adaptor-related protein complex 1 (PF13_0062), polymerase RNA I (PF11_0358) - DNA repair:
DNA primase (PF14_0366 and PFI0530c), rpa1 (PFI0235w) - Protein folding: ferredoxin reductase (PF11_0407), Hsp10 (PFL0740c), Hsp60 (PF10_0153),
Hsp70 (PF11_0351 and PF08_0054), Hsp90 (PFL1070c and PF07_0029), prohibitin (PF08_0006), DnaJ (PFF1415c). (B) Representation of ATP-
dependent gene sub-networks altered in hyperoxic conditions. V-type ATPase: V-type ATPase putative (MAL13P1.271), vacuolar ATP synthase
subunit h putative (PF13_0034), vacuolar ATP synthetase putative (PFE0965c), vacuolar ATP synthase subunit F putative (PF11_0412), vacuolar ATP
synthase subunit D putative (PF13_0227), vacuolar ATP synthase catalytic subunit a (PF13_0065) - Mitochondrial ATP synthase F1: ATP synthase
subunit putative (PF14_0615), mitochondrial ATP synthase F1 epsilon subunit (MAL7P1.75), mitochondrial ATP synthase F1 alpha subunit putative
(PFB0795w). Red and blue colors correspond respectively to up- and down-regulated genes compared between hyperoxic to normoxic
conditions.
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and post-translational modification. Among the four
spots detected (spot numbers 1301, 1314, 1326, and
1331) as Pf-Hsp70 protein [PlasmoDB: PF08_0054,
GenBank: gi|124512406], only two isoforms were signifi-
cantly up-regulated in hyperoxic conditions (Table 2 and
Figure 5). These results indicated that the hyperoxia
response could induce post-translational regulation of
several parasite proteins.
To determine the metabolic pathways perturbed follow-
ing hyperoxia, the identified proteins were classified
using the NCBI COG database. The proportion of
modulated proteins involved in each functional category
w a sd e t e r m i n e da sf o l l o w s .F o rP. falciparum,s i xf u n c -
tional categories were found to be altered, among which
were chaperone-assisted protein folding, translation,
antioxidant metabolism and glycolysis, which were
already identified in transcriptomic analysis. For Homo
sapiens, the identified proteins were classified into three
functional categories: antioxidant metabolism, glycolysis
and O2 transporter (Table 2).
The 2D-DIGE analyses also indicated the accumula-
tion of some proteins involved in digestive vacuole
metabolism such as human catalase [GenBank: gi|
4557014] and beta-globin [GenBank: gi|183817]. The
accumulation of beta-globin suggests proteases
inhibition of the beta-globin degradation pathway. To
explore this hypothesis, the transcripts of four genes
[PlasmoDB: PF14_0077, PF11_0161, PF11_0165,
PF11_0162] were quantified using real-time qRT-PCR as
described above (Additional file 1). All genes involved in
digestive vacuole metabolism were found to be down-
expressed (Figure 6).
Discussion
In vivo, the P. falciparum parasite is subjected to varying
oxygen levels throughout its life cycle (i.e., from 5% O2
in human venous blood to 13% O2 in the human lungs
and 21% O2 in mosquito salivary glands). In the
mosquito, the metabolic adaptation of parasite to
oxygen-rich environment involved mitochondrial and
physiological differences [32]. These oxygen variations
imply that metabolic adaptation of P. falciparum is cru-
cial for it survival. During malaria complications such as
acute respiratory distress syndrome, late-ring stage para-
sites are susceptible to sequestration in pulmonary capil-
laries and are thus exposed to hyperoxic conditions [33].
These sequestered young parasites could be exposed to
higher oxygen levels than the physiologically relevant O2
tension. Additionally, Blanco et al reported that hyper-
baric oxygen therapy (HBO, 100% O2) has a beneficial
effect on malaria syndrome evolution [34]. Indeed,
Figure 3 Validation of microarray data by qRT-PCR. Data from qRT-PCR and a microarray of eight selected genes were compared between
hyperoxic and normoxic conditions. Adjacent bars correspond to the mean log2 (fold change) and respective standard deviation and present
qRT-PCR and microarray results in gray scale for the respective gene. The abbreviations and their corresponding gene IDs (PlasmoDB accession
numbers) are indicated below the graphic. Crude values of mean fold changes are presented in the table. The same samples were used for the
qRT-PCR and microarray experiments. gapdh: glyceraldehyde-3-phosphate dehydrogenase - gf6p: glutamine-fructose-6-phosphate transaminase -
gst: glutathione S-transferase - pka: protein kinase A - atp6: mitochondrial ATP synthase F0 a subunit - atp4: mitochondrial ATP synthase F0 b
subunit.
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the malaria parasite to hyperoxia could help to develop
new anti-malarial drug treatments that could be used
in association with HBO treatment. To study the global
response of P. falciparum to hyperoxia, a dual high-
throughput approach combining microarray and
2D-DIGE analysis was used on parasite cultures under
hyperoxic conditions (e.g., 21% O2). Accordingly Hsp90,
Hsp70, GAPDH, and elongation factor 1 and 2 were
found to be altered at the transcript and protein levels
under hyperoxia.
Since the development of high-throughput technolo-
gies, few studies have been published regarding the
transcriptome and proteome of P. falciparum in
response to environmental constraints or drug
treatments [35-40]. Since hyperoxia induces a P. falci-
parum cycle delay, the sample collections were per-
formed before the phenotypic effect. Although the
majority of genes had a periodic expression profile [41],
RNA transcription is maximal between 18 and 24
hours of the parasitic cycle [42]. In the present study,
sample collections were per f o r m e da tt h el a t e - r i n g
parasite stage. Moreover, as a delay exists between
mRNA and protein accumulation [43-45], the time of
exposure was also taken into account and a four hours
delay was chosen between mRNA and protein sam-
pling. It has been suggested that there may be a discre-
pancy between P. falciparum transcriptomic and
proteomic responses [35,39]. Preliminary microarray
experiments were performed with transcripts from
Figure 4 Alterations of the P. falciparum proteome under hyperoxic exposure. The proteins from P. falciparum parasites cultivated under
normoxic (A) or hyperoxic (B) conditions were labelled with Cy3 and Cy5, respectively, and separated by 2-DE using a 10% homogeneous SDS
polyacrylamide gel with a pH range from 3 to 10. As determined by DeCyder software, protein spots that were down- (A) or up- (B) regulated
following hyperoxic exposure (|FC|≥1.5, p ≤ 0.05) are marked with master numbers (Table 2 and Additional file 5). Bold and italic numbers
correspond, respectively, to proteins identified from P. falciparum and Homo sapiens. Areas of gels containing a high density of spots down- and
up-modulated are enlarged.
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Page 8 of 15Table 2 Proteins identified by differential 2-D DIGE analysis following hyperoxia exposure of P. falciparum
gi
numberc
Gene ID Protein name MW
(kDa)
pI Master spot
number
Significance
(Mascot score)
Average
ratio
t-Test
P. falciparum
Translation
gi|
124512420
MAL8P1.69 14-3-3 protein homologue 29.86 4.96 3289 425 -1.54 0.0078
gi|
124513850
PF13_0304 elongation factor 1 alpha 49.16 9.12 2047 130 1.60 0.0090
gi|8918238 PF14_0486 elongation factor 2 85.03 6.30 1030 67 1.72 0.0070
gi|
124810293
PF14_0655 RNA helicase-1 45.62 5.48 2268 105 1.53 0.040
Parasitophorous vacuolar membrane Transporter
gi|
124810348
PF14_0678 exported protein 2 33.62 5.10 3061 88 -1.92 0.00093
3062 180 -2.06 0.0046
Glycolysis
gi|
124809201
PF14_0341 glucose-6-phosphate isomerase 67.61 6.78 1579 36 -1.63 0.00092
gi|
124810131
PF14_0598 glyceraldehyde-3-phosphate
dehydrogenase
37.08 7.59 2867 695 -1.69 0.033
Chaperone-assisted protein folding
gi|
124512406
PF08_0054 heat shock protein 70 74.39 5.51 1314 257 1.65 0.03
1326 137 1.58 0.026
gi|505340 PF07_0029 heat shock protein 86 86.77 4.91 1028 412 1.50 0.0052
Amino acids metabolism
gi|
86170756
PFF0435w ornithine aminotransferase 47 6.47 2217 96 -2.14 0.0081
gi|
124513590
MAL13P1.214 phosphoethanolamine 31.31 5.43 3347 145 -2.05 0.0055
N-methyltransferase 3372 252 -1.96 0.00089
3379 253 -2.17 0.00058
3503 52 -1.62 0.00056
3385 452 -2.71 0.00026
Proteasome-mediated proteolysis
gi|
124512686
MAL8P1.142 proteasome beta-subunit 31.08 6.00 3216 58 1.78 0.015
gi|
124513790
MAL13P1.270 proteasome subunit 27.50 6.17 3358 142 1.55 0.049
Homo sapiens
Oxygen transporter
gi|183817 Beta-globin 19.21 6.28 3451 165 7.71 0.020
3576 102 1.91 0.011
Antioxidant metabolism
gi|4502517 carbonic anhydrase I 28.91 6.59 3431 173 4.18 0.0095
3444 155 3.47 0.0019
3455 224 4.02 0.00038
gi|4557014 catalase 59.95 6.9 1648 200 6.47 0.012
gi|
16306550
selenium binding protein 1 52.93 5.93 2451 73 -1.64 0.041
gi|
168985379
flotillin 1 39.81 6.03 2156 157 1.64 0.040
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Page 9 of 15synchronized P. falciparum in the same experimental
scheme, but the samples were collected after four
hours of hyperoxia treatment. These microarray ana-
lyses indicated that 176 transcripts were significantly
deregulated (|FC|≤ 1.5, p ≤ 0.01, Student’s t-Test), and
some genes significantly deregulated were involved in
the early antioxidant response, such as 1-cys peroxi-
doxin [PlasmoDB: PF08_0131], Fe-superoxide dismutase
[PlasmoDB: PF08_0071] and thioredoxin peroxidase
[PlasmoDB: MAL7P1.159] (Additional file 6). This early
stress response is generally observed in stress condition
does not reflect a specific hyperoxia adaptation [30,46].
Here, despite significantt r a n s c r i p tv a r i a t i o n s( p ≤ 0.01,
Student’s t-Test), gene fold-changes observed were low
(|FC|≤ 1.5) under hyperoxia. The low-level changes
observed in the P. falciparum transcriptome could be
explained by tight gene regulation [47,48] or by post-
transcriptional regulation of most P. falciparum genes
[43-45]. Consequently, analysis of the parasite’sa d a p -
tive response to hyperoxia requires the use of extremely
successful bioinformatic tools for microarray data inter-
pretation such as PS 6.0 software [44,49], and this
Table 2 Proteins identified by differential 2-D DIGE analysis following hyperoxia exposure of P. falciparum (Continued)
Glycolysis
gi|31645 glyceraldehyde-3- 36.20 8.26 2804 199 -1.94 0.0042
phosphate dehydrogenase 2806 181 -1.99 0.012
2807 132 -1.84 0.0069
2853 112 -2.17 0.0027
2854 122 -2.25 0.0032
2856 96 -2.20 0.0019
The proteins were identified by mass spectrometry following in gel trypsin digestion. The spot numbers correspond to the same numbers in figure 4. The Mascot
gi number of the spots, their gene ID (PlasmoDB), their name, the theoretical MW and pI values, as well as the corresponding Mascot score are listed for MS/MS
analysis (scores greater than 29 for P. falciparum and 38 for Homo sapiens are considered significant (p ≤ 0.05)). Paired average volume ratio (hyperoxic versus
normoxic conditions) and p-values (t-Test) were obtained using Decyder software. MW: molecular weight.
Figure 5 Selective post-translational modification of Pf-Hsp70 following hyperoxia exposure. (A) Enlarged 2D-DIGE gel images and their
corresponding three-dimensional profiles are shown for a series of four protein spots identified as Pf-Hsp70. The amount of protein is
proportional to the volume peak. Numbers correspond to master gel and significant deregulated spots (i.e., 1314 and 1326) are reported in the
table 2. (B) A graphic quantification of the four spots corresponding to Pf-Hsp 70 under normoxic (light-gray bars) and hyperoxic conditions
(dark-gray bars). Spot numbers are specified at the bottom. Adjacent bars correspond to the mean standard abundance and respective standard
deviation. Fold change and p-values are indicated at the bottom for each spot. A.U.: arbitrary units, FC: fold change.
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mic approach such as 2D-DIGE.
It is generally accepted that one of the first effects of
hyperoxia is ROS overproduction (superoxide anions
(O
-
2), hydrogen peroxide (H2O2) and hydroxyl radicals
(OH
-)), which is generated by metabolism, and particu-
larly, by respiratory metabolism [50]. DNA, lipid, and
protein alterations by ROS may be lethal to malaria
parasites. Thus, to fight oxidative stress, P. falciparum
has developed an adaptive defence response including
repair mechanisms for nucleic acids and proteins
[29,51]. Despite high ROS defence system expression
under normoxia, transcriptomic analysis suggests an up-
regulation of ROS defence systems [29]. Five genes
involved in DNA repair were found to be up-regulated
during hyperoxia. Among them, two sub-unities of DNA
primase [PlasmoDB: PF14_0366 and PFI0530c]a n d
replication protein A1 [PlasmoDB: rpa1, PFI0235w] have
been described to be involved in chromosomal replica-
tion [52,53]. Rpa1 was reported also to interact with
rad51 [PlasmoDB: PF11_0087] in nucleosomes during
replication to correct DNA mismatches [51,54]. And
Hsp40 [PlasmoDB: DNAJ homologue, PFF1415c] is asso-
ciated with DNA repair and the replication machinery
[55]. These observations suggest that DNA repair
enzymes maintain the integrity of the parasitic genome
under high oxygen pressure.
Protein oxidation caused by ROS is circumvented by
diverse functions such as regulation of the redox state
and modulation of protein stability [56]. Chaperone pro-
teins, Hsps known as stress response proteins, further
assure this protection. Several proteins involved in cha-
perone activity including Hsp40 [PlasmoDB: DNAJ
homologue; PFF1415c], Hsp60 [PlasmoDB: PF10_0153],
Hsp70 [PlasmoDB: PF11_0351 and PF08_0054], Hsp90
[PlasmoDB: PFL1070c and PF07_0029], and protein
14-3-3 [PlasmoDB: MAL8P1.69] were found up-regulated
under hyperoxia. As described by Akide-Ndunge et al
[57], Hsp60 is up-regulated under oxidative stress like
hyperoxia and its expression is coordinated with antiox-
idant enzymes in a stage-dependent manner, suggesting
thus that Hsp up-regulation is implicated in ROS
removal. Elsewhere, Pf-Hsp70 forms a functional net-
work in the mitochondrial matrix with DNAJ, Hsp60
and prohibitin to be involved in post-translational mod-
ification of proteins [56]. Isoforms of Hsp70 were
detected following hyperoxia exposure, which may also
correspond to post-translational modification as pre-
viously predicted [58,59]. These Hsps, which act as
sensors of environmental conditions, are involved in
adaptation mechanism by post-translational modifica-
t i o n[ 5 6 ] .H o w e v e r ,t h er o l eo fthese post-translational
modifications on regulation of protein expression in
P. falciparum is little known [38,39]. Nevertheless, the
Figure 6 Analysis of the beta-globin digestion pathway. qRT-PCR and microarray data of transcripts involved in digestive vacuole
metabolism were compared between hyperoxic and normoxic conditions. Adjacent bars correspond to the mean log2 (fold change) and
respective standard deviation and present qRT-PCR and microarray results in gray scale for the respective gene. The abbreviated names and their
corresponding gene ID (PlasmoDB accession numbers) are indicated below the graphic. Crude values of mean fold changes are presented in the
table. The same samples were used for the qRT-PCR and microarray experiments.
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the hyperoxia response and facilitate P. falciparum
adaptation to hyperoxic environments.
Under hyperoxia, down-regulation of glycolytic
enzymes (glucose-6-phosphate isomerase [PlasmoDB:
PF14_0341] and glyceraldehyde-3-phosphate dehydro-
genase [PlasmoDB: GAPDH, PF14_0598]) was detected
in this study. Additionally, three enzyme involved in de
novo pyrimidine biosynthesis were found up-regulated
such as carbonic anhydrase [GenBank: gi|4502517], car-
bamoyl-phosphate synthetase [PlasmoDB: PF13_0044]
and aspartate carbamoyltransferase [PlasmoDB:
PF13_0240] [60]. This last, up-expressed in microarray
analysis, produces dihydroorotate oxidase (DHO), an
essential substrate of mitochondrial respiratory chain
complex II [61]. This pyrimidine pathway is essential for
nucleic acid synthesis to repair DNA lesions caused by
the oxidative stress. Microarray data indicated that
alpha and epsilon ATP synthase F1 subunits [PlasmoDB:
PFB0795w and MAL7P1.75] were up-regulated, indicat-
ing that parasites seem to produce ATP through mito-
chondrial respiration. Mitochondrial F0F1 ATP synthase
is composed of two subcomplexes, F0 and F1. F1 is com-
posed of five subunits, and these have been reported in
the P. falciparum genome [62]. Recently, Mogi and Kita
have identified four F0 subunits of P. falciparum ATP
synthase [63,64] and Mather et al. support the existence
of ATP synthase activity [65]. Two transcripts of ATP
synthase F0 subcomplexe, a subunit (ATP6) and b subu-
nit (ATP4), were up-regulated under hyperoxia expo-
sure, which is in favour of a mitochondrial respiration.
To adapt to hyperoxia, P. falciparum seems switch from
anaerobic glycolysis to aerobic respiratory metabolism
(Figure 7).
Figure 7 A schematic representation of P. falciparum metabolic adaptation to hyperoxia exposure. Metabolic pathways based on the
Ginsburg Pathway [72] for glycolysis (cytoplasmic), respiratory chain (mitochondria, blue and yellow) and haemoglobin digestion (digestive
vacuolar, orange) are shown. The gene IDs (PlasmoDB) are reported for each enzymatic reaction. Human protein names are underlined. Up- and
down-regulated genes and reactive oxygen species (ROS) production are indicated in red and blue characters, respectively.
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vacuole is another ROS source organelle in P. falciparum
during haemoglobin digestion [10]. Haemoglobin diges-
tion is optimal at an acidic pH, which is also necessary
for protease activity. To provide the acidic environment
in the digestive vacuole, haemoglobin digestion stimu-
lates ATP consumption by the V-type H
+-ATPase
pump [66-68]. In microarray analysis, the V-type
ATPase complex [PlasmoDB: MAL13P1.271, PF13_0034,
PFE0965c, PF11_0412, PF13_0227, PF13_0065], a mem-
brane transporter, was found to be down-regulated
under hyperoxia. Therefore, P. falciparum exposed to
hyperoxia could generate a pH change in the digestive
vacuole responsible for vacuolar protease activity. Addi-
tionally, beta-globin accumulation occurred in hyperoxic
conditions. This beta-globin accumulation could result
from a decline in protease activity. To test these two
hypotheses, transcripts of the proteases involved in
beta-globin degradation were quantified. Reduced
expression of four genes involved in haemoglobin
degradation into AAs (plasmepsin 2 [PlasmoDB:
PF14_0077], falcipain 2 putative [PlasmoDB:
PF11_0161], falcipain 2 precursor [PlasmoDB:
PF11_0165]a n dfalcipain 3 [PlasmoDB: PF11_0162])
was validated using qRT-PCR. In 2002, Oliveira et al
hypothesized that blood-feeding parasites reduced their
mitochondrial function to compensate for ROS genera-
tion from the digestive vacuole [10].
Moreover, catalase [GenBank: gi|4557014], a human
protein, was found concentrated in the digestive vacuole
[69]. As the P. falciparum genome does not contain
a catalase gene, the parasite may import human catalase
to detoxify H2O2 generated by oxidation of haem under
stress conditions. Collectively, metabolism in the
P. falciparum digestive vacuole would be perturbed in
response to hyperoxia, and ROS production would be
slowed (Figure 7).
Conclusions
Two complementary analytic approaches were used to
investigate the response of P. falciparum to hyperoxia;
(i) a transcriptomic study allowed us to detect whole
parasite transcripts, and (ii) a proteomic study identified
proteins significantly altered via post-translational modi-
fications and accumulated host proteins. Based on all
these results and according to published data mining
[29,46], a schematic representation of the adaptive
response of P. falciparum following hyperoxia exposure
was proposed (Figure 7). In order to prove this repre-
sentation, further biochemical approaches would be
required.
Hyperoxia exposure induces metabolic adaptations in
P. falciparum. These adaptations seem to involve, at
least, two parasite organelles, the digestive vacuole and
the mitochondrion, both sources of ROS production. To
preserve parasite integrity from oxidative stress, all these
data suggest that the glycolysis pathway is suppressed in
favour of respiratory metabolism and that digestive
vacuole metabolism is slowed. Campanale et al demon-
strated that stress caused by haemoglobin digestion
modulates the glycolytic pathway [70]. Highly active
mitochondria release H2O2, which interacts with pro-
oxidant products (free iron and haem) in the digestive
vacuole. These two ROS sources could be potentially
synergistic. The equilibrium of oxidative stress is vital
for the parasite; indeed, Hsps could be regulated to facil-
itate adaptation of parasite to environmental stress as
observed in many organisms [56].
The knowledge of the metabolic pathways involved in
stress responses to environmental conditions is funda-
mental to understanding the mechanisms of parasite
adaptation. This study provides a starting point for
investigations into new anti-malarial treatments, particu-
larly drugs associated with hyperbaric oxygen therapy
[34], which has been successfully used to treat other
infections [71].
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